United Kingdom

Trisha Roy

Boston Scientific sees improved July trends as elective surgery recovers

29 Jul 2020

Medical device maker Boston Scientific Corp on Wednesday posted a surprise adjusted quarterly profit and said demand for elective procedures picked up pace in July following an easing of coronavirus-driven restrictions.

Walgreens CEO Stefano Pessina to step down

27 Jul 2020

Walgreens Boots Alliance Inc said on Monday its biggest shareholder, Stefano Pessina, will step down as the chief executive officer after five years at the helm, during which the pharmacy group's value more than halved.

Biogen lifts full-year profit forecast as Tecfidera boosts quarter

22 Jul 2020

Biogen Inc raised its 2020 earnings forecast on Wednesday after better-than-expected sales of its multiple sclerosis treatment Tecfidera helped the drugmaker beat second-quarter profit estimates.

Abbott sees no hit to demand for COVID-19 tests from vaccine

16 Jul 2020

Abbott Laboratories said on Thursday demand for its coronavirus tests will likely remain high even after a safe and effective vaccine is available as the medical device maker forecast full-year profit above analysts' estimates.

UPDATE 2-U.S. government agrees to buy Becton's COVID-19 testing devices

15 Jul 2020

July 15 The U.S. government will buy Becton, Dickinson and Co's COVID-19 testing devices and kits, the company said on Wednesday, as it ramps up its testing for the virus that has been spreading at an alarming rate.

Walgreens swings to loss on $2 billion Boots UK charges due to COVID-19

09 Jul 2020

Walgreens Boots Alliance Inc said on Thursday it would close stores, cut jobs and suspend share repurchase as the coronavirus crisis hammered its ailing Boots UK division, leading to a $2 billion impairment charge in the third quarter. | Video

Regeneron starts COVID-19 antibody cocktail late-stage trials, shares rise

06 Jul 2020

Regeneron Pharmaceuticals Inc said on Monday it has started late-stage clinical trials to assess the effectiveness of its antibody cocktail in preventing and treating COVID-19.

Inovio's COVID-19 vaccine candidate shows promise in small early-stage trial

30 Jun 2020

An experimental coronavirus vaccine developed by Inovio Pharmaceuticals Inc showed promise and was found to be safe in an early-stage human trial, the company said on Tuesday.

World News